These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6155610)

  • 21. Formation of DNA adducts from N-acetoxy-2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in rat hemopoietic tissues in vivo.
    Vu VT; Grantham PH; Roller PP; Hankins WD; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1986 Jan; 46(1):233-8. PubMed ID: 3940194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative and qualitative aspects of the binding of N-hydroxy-2-acetylaminofluorene to hepatic chromatin fractions.
    Schwartz EL; Goodman JI
    Chem Biol Interact; 1979 Aug; 26(3):287-303. PubMed ID: 509692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beland FA; Dooley KL; Jackson CD
    Cancer Res; 1982 Apr; 42(4):1348-54. PubMed ID: 6949639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo binding of N-2-acetylaminofluorene and its N-hydroxy derivative to the DNA of fractionated rat liver chromatin.
    Walker MS; Becker FF; Rodriguez LV
    Chem Biol Interact; 1979 Oct; 27(2-3):177-90. PubMed ID: 498353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic studies on in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in rat liver containing gamma-glutamyltranspeptidase-positive foci. The effect of the sulfation-inhibitor pentachlorophenol.
    Kroese ED; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Apr; 8(4):571-5. PubMed ID: 2881632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo.
    Allaben WT; Weis CC; Fullerton NF; Beland FA
    Carcinogenesis; 1983 Aug; 4(8):1067-70. PubMed ID: 6872152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes.
    Yamazoe Y; Ishii K; Yamaguchi N; Kamataki T; Kato R
    Biochem Pharmacol; 1980 Aug; 29(16):2183-8. PubMed ID: 7426024
    [No Abstract]   [Full Text] [Related]  

  • 31. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
    Lai CC; Miller JA; Miller EC; Liem A
    Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene.
    Holme JA; Søderlund EJ
    Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene.
    Gupta RC; Dighe NR
    Carcinogenesis; 1984 Mar; 5(3):343-9. PubMed ID: 6705140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles.
    Smith BA; Springfield JR; Gutmann HR
    Carcinogenesis; 1986 Mar; 7(3):405-11. PubMed ID: 3512117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of the hepatotoxic action of N-hydroxy-2-acetylaminofluorene in the rat by inhibition of N-O-sulfation by pentachlorophenol.
    Meerman JH; Mulder GJ
    Life Sci; 1981 May; 28(21):2361-5. PubMed ID: 7253825
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of N-hydroxy acetylaminofluorene to eu- and heterochromatin fractions of rat liver in vivo.
    Moyer GH; Gumbiner B; Austin GE
    Cancer Lett; 1977 Mar; 2(4-5):259-65. PubMed ID: 45728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids.
    Kolanczyk RC; Gutmann HR; Rutks IR
    Chem Res Toxicol; 1992; 5(2):274-9. PubMed ID: 1643258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
    Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
    Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.